Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-057062
Filing Date
2021-09-21
Accepted
2021-09-21 17:10:25
Documents
1
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4003
  Complete submission text file 0001209191-21-057062.txt   5344
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address
ROOT JONATHAN D (Reporting) CIK: 0001225480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 211267151

Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations